Map SBIR Recipient Corporate Structures into Commercialization Intelligence Dossiers
- Organization
- SBIR recipients with complex corporate structures and publicly disclosed principal backgrounds
- Sector
- Microfluidic commercialization consultancies and specialized investors
- Location
- Georgia/Delaware
Source reference
Executive summary
Current state
NSF awarded DELEON TECHNOLOGIES $305K SBIR Phase I funding to develop a disposable microfluidic chip for urine analysis, creating a classic "SBIR Valley of Death" scenario where government-funded technical capability exists without commercial infrastructure for FDA clearance, manufacturing scale, or data monetization.
Market catalyst
SBIR recipients' corporate structures and principal backgrounds are publicly accessible but unanalyzed - commercialization specialists need this intelligence to time their partnership offers but lack the OSINT capability to compile it efficiently
This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.
Field notes
Intelligence ledger
Add new evidence, corrections, or practical context to this directive. Keep claims attributable to a source where possible.
Sign in to add intelligence or vote on a field note.
Field intel logs: [ 0 ] entries. No operative updates submitted for this directive. Submit intel to claim clearance.